Literature DB >> 17297303

The role of CD44 in HNSCC.

Aaron D Nelson1, Jennifer R Grandis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17297303     DOI： 10.4161/cbt.6.1.3898

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  2 in total

1.  Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.

Authors:  Carlos Torre; Steven J Wang; Weiliang Xia; Lilly Y W Bourguignon
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-05

2.  Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.

Authors:  M Athanassiou-Papaefthymiou; O Shkeir; D Kim; V Divi; M Matossian; J H Owen; M J Czerwinski; P Papagerakis; J McHugh; C R Bradford; T E Carey; G T Wolf; M E Prince; S Papagerakis
Journal:  Int J Immunopathol Pharmacol       Date:  2014 Jul-Sep       Impact factor: 3.219
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.